Save the Date! Interactive User Group Meeting in Baltimore, MD

04/07/2018

We’re having our second Interactive User Group Meeting on Monday, October 1st 2018, 1pm – 5pm EDT in Baltimore, MD! The User Group Meeting will be a forum not only for us to provide you with the most recent Holotype HLA v3 product updates, but also for you to hear and...

Benefits of HLA Typing by NGS for Organ Transplantation

03/07/2018

Mette Christiansen (Aarhus University Hospital) was focusing on the benefits of HLA typing by NGS for organ transplantation during her User Group Meeting talk at the EFI 2018 conference. The presentation includes slides of the use of high-resolution (vs. low-resolution) typings in solid organ transplantation. Download the full presentation...

“Companies need to play a leadership in helping labs to adopt the most efficient implementations of new technologies” – Interview with Dr. Attila Berces, Founder of Omixon

28/06/2018

This interview is part of a series that we are conducting with Key Opinion Leaders, Experts and Business Managers within the HLA field. This time, Mr. Attila Berces, Ph.D., Founder and Chairman of Omixon shares his thoughts about future technology improvements. We hope this series will shed a light...

NGS Workflow in a Low Throughput Lab

20/06/2018

In her EFI 2018 User Group Meeting presentation, Dr. Sonja Verheyden (UZ Brussels) talked about issues that a small, low throughput lab can face, why they consider next-generation sequencing for HLA typing and how to make NGS cost-effective in a lab like UZB? You can download her presentation...

Omixon Announce Partnership with Dilen s.r.o.

30/05/2018

Omixon announce today a new partnership with Dilen s.r.o. appointed as our exclusive distributor for all our products in Kazakhstan. Dilen s.r.o. will distribute and provide technical support for all our products to existing and new customers in the country. Dilen s.r.o., founded in 1994 and has its headquarters in Prague,...